Conivaptan Hydrochloride Injection — FDA Drug Shortage

Current — Cumberland Pharmaceuticals Inc.

The FDA lists a drug shortage record for Conivaptan Hydrochloride Injection (injection) from Cumberland Pharmaceuticals Inc. with status Current. The shortage was first posted on Mar 14, 2022. Reported reason: Delay in shipping of the drug

Shortage details

Status
Current
Company
Cumberland Pharmaceuticals Inc.
Package NDC
66220-160-10
Dosage Form
Injection
Presentation
Vaprisol Dextrose In Plastic Container, Injection, 20 mg/100 mL (NDC 66220-160-10)
Initial Posting
Mar 14, 2022

Reason

Delay in shipping of the drug

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.